The Orphan Drug Tax Credit applies to qualified clinical trial expenses designated for rare disease or conditions. These conditions are usually called “orphan drugs”.
The orphan drug tax credit covers 50% of the clinical testing expenses, reducing the costs of developing drugs and products for small patient population.
"This orphan drug designation along with encouraging research results represents ... and tax credits for clinical testing expenses conducted after orphan ...
Athersys received orphan drug designation from the US Food and Drug Administration for ... study-design assistance, tax incentives and seven years of market ...
Our Q4 non-GAAP tax rate was 24.3%, benefiting from a higher level of orphan drug research credits in favorable settlements from prior-year audits.
FDA officials have pointed out that orphan drugs must prove probable benefit and ... application fee waivers, and tax credits for up to 50% of R&D costs.
Want to guarantee that the IRS can't touch you? Free information on what binds the IRS to a payment plan, assuring that they will never take your assets.
| Find us on... | |
|---|---|
| Angie's list | |
| Craigslist | |
| Yahoo questions | Citysearch |
| QuickBooks | Google place pages |
| Tax Blogs | |
